On Tuesday shares of Immunomedics Inc. (NASDAQ:IMMU) closed at $4.01. Company’s sales growth for last 5 years was -21.40%. Immunomedics, Inc. (NASDAQ:IMMU) announced the issuance of U.S. Patent No. 9,028,833 for a new patent family “Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.”
On Tuesday shares of iBio, Inc. (NYSEMKT:IBIO) closed at $0.84. Company’s sales growth for last 5 years was -30.10%. On 6 May, Ibio Inc (NYSEMKT:IBIO) declared the issue of a new U.S. patent expanding the company’s iBioModulator™ thermostable immunomodulator protein portfolio. The new patent, serial number 9,012,199, is entitled “Recombinant Carrier Molecule for Expression, Delivery, and Purification of Target Polypeptides.” The fundamental composition of matter claims grant iBio important exclusivity over new, modified carrier molecules derived from the company’s proprietary iBioModulator™ thermostable immunomodulator protein system and their use with one or more target proteins or antigens.
On last trading day Staples, Inc. (NASDAQ:SPLS) fell -1.08% to close at $16.47. Its volatility for the week is 1.64% while volatility for the month is 1.75%. SPLS’s sales growth for past 5 years was -1.50% and its EPS growth for past 5 years was -27.10%. Staples, Inc. (NASDAQ:SPLS) monthly performance is 1.48%. Staples, Inc. (NASDAQ:SPLS) Wednesday announced a partnership with Bidvest Waltons, a South African office products company, and Dacris, a distributor of office supplies in Romania. The company expects the partnerships would help to grow presence in EMEA region.
Zix Corporation (NASDAQ:ZIXI) has 1.10% insider ownership while its institutional ownership stands at 66.90%. In last trading activity company’s stock closed at $4.70. Zacks restated their hold rating on shares of Zix Corp. (NASDAQ:ZIXI) in a report issued on 1 May.
On last trading day Blue Nile Inc. (NASDAQ:NILE) fell -1.82% to close at $28.11. Its volatility for the week is 5.91% while volatility for the month is 3.77%. NILE’s sales growth for past 5 years was 9.40% and its EPS growth for past 5 years was -1.00%. Blue Nile Inc. (NASDAQ:NILE) monthly performance is -2.63%. Blue Nile, Inc. (NASDAQ:NILE) on 8 May, reported financial results for its first quarter ended April 5, 2015. Net sales increased 2.6% to $106.5 million for the first quarter ended April 5, 2015 compared to $103.7 million for the first quarter ended March 30, 2014. Operating income for the quarter totaled $1.9 million, representing an operating margin of 1.8% of net sales compared to $1.6 million of operating income and 1.6% of operating margin for the first quarter of 2014. Net income totaled $1.2 million, or $0.10 per diluted share versus $1.1 million, or $0.08 per diluted share for the first quarter of 2014.